Curation Collective has written an article covering the three reasons why you should care about MYCELX and the wider per- and poly-fluoroalkyl substances (PFAS) treatment market.  This article is based upon their discussion with MYCELX, and includes a link to the recording of that discussion.  The article begins:

“Three reasons why you should care about Mycelx and the wider per- and poly-fluoroalkyl substances (PFAS) treatment market:

    1. Vast addressable market: Estimates suggest the PFAS treatment market in the US alone is worth $14bn per annum. Decontaminating landfill leachate, industrial waste, municipal water facilities, and residential water supply are all key growth sectors.
    2. Evolving regulatory landscape: Litigation cases against corporations accused of releasing PFAS into the environment are growing, and the regulatory landscape is evolving rapidly – the financial penalties associated with PFAS pollution are increasingly front-of-mind for companies handling the substances.
    3. Mainstream social issue – The PFAS issue is firmly entrenched in the public imagination after a series of high-profile public health and environmental scandals. Exposure mirrors that of chlorofluorocarbons (CFCs) in the 1990s – demand is high for organisations offering PFAS treatment solutions.”

You can read the complete article posted out on Linked in by clicking on the link below:

PFAS: Will these ‘forever’ chemicals be a forever problem? – Curation Collective